share_log

What Analysts Are Saying About Johnson & Johnson Stock

What Analysts Are Saying About Johnson & Johnson Stock

分析师们对强生股票的看法
Benzinga ·  15:00
17 analysts have expressed a variety of opinions on Johnson & Johnson (NYSE:JNJ) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去一个季度,有17位分析师就庸氏(纽交所:JNJ)发表了各种观点,从看好到看淡,观点多样。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况,突出了过去30天内情绪的变化,并将其与之前的月份进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Johnson & Johnson, presenting an average target of $193.94, a high estimate of $215.00, and a low estimate of $150.00. This current average has decreased by 0.6% from the previous average price target of $195.12.
在对于12个月价格目标的评估中,分析师们揭示了关于强生公司的见解,提出了一个平均目标价为193.94美元,最高估值为215.00美元,最低估值为150.00美元。当前这一平均值相较于之前的195.12美元目标价下降了0.6%。
Investigating Analyst Ratings: An Elaborate Study...
分析师评级的...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发